Rocket


News + Filings
Transactions





Fust Matthew K

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/07/2023Ultragenyx Pharmaceutical Inc.RAREGrantStock Option (Right to Buy)7.1k$51.82$368.4k 06/07/2023
06/07/2023Ultragenyx Pharmaceutical Inc.RAREDispositionCommon Stock3.3k$51.82$171k 06/07/2023
06/07/2023Ultragenyx Pharmaceutical Inc.RAREGrantCommon Stock3.9k$0.00$0 06/07/2023
05/31/2023Atara Biotherapeutics, Inc.ATRAGrantNon-Qualified Stock Option (Right to Buy)79.5k$1.53$121.6k 05/31/2023
05/31/2023Atara Biotherapeutics, Inc.ATRAGrantCommon Stock57k$0.00$0 05/31/2023
07/13/2022Crinetics Pharmaceuticals, Inc.CRNXSaleCommon Stock5.7k$20.96$119.5k 07/13/2022
07/13/2022Crinetics Pharmaceuticals, Inc.CRNXExerciseNon-qualified stock option (Right to Buy)5.7k$1.45$8.3k 07/13/2022
06/24/2022Ultragenyx Pharmaceutical Inc.RAREGrantCommon Stock3.3k$0.00$0 06/24/2022
06/24/2022Ultragenyx Pharmaceutical Inc.RAREGrantStock Option (Right to Buy)6.2k$60.57$378.3k 06/24/2022
06/23/2022Atara Biotherapeutics, Inc.ATRAGrantCommon Stock20.5k$0.00$0 06/23/2022
06/23/2022Atara Biotherapeutics, Inc.ATRAGrantNon-Qualified Stock Option (Right to Buy)31.5k$7.35$231.5k 06/23/2022
06/17/2022Crinetics Pharmaceuticals, Inc.CRNXGrantStock Option (right to buy)17.5k$18.29$320.1k 06/17/2022
03/04/2022Ultragenyx Pharmaceutical Inc.RAREExerciseStock Option (Right to Buy)7.5k$40.37$302.8k 03/04/2022
11/04/2021Atara Biotherapeutics, Inc.ATRASaleCommon Stock13.4k$19.50$260.4k 11/04/2021
11/01/2021Crinetics Pharmaceuticals, Inc.CRNXSaleCommon Stock9k$25.50$228.3k 11/01/2021
11/01/2021Crinetics Pharmaceuticals, Inc.CRNXExerciseNon-qualified stock option (Right to Buy)9k$1.91$17.1k 11/01/2021
09/08/2021Crinetics Pharmaceuticals, Inc.CRNXSaleCommon Stock6k$25.50$154.2k 09/08/2021
09/08/2021Crinetics Pharmaceuticals, Inc.CRNXExerciseNon-qualified stock option (Right to Buy)6k$1.91$11.5k 09/08/2021
07/26/2021Crinetics Pharmaceuticals, Inc.CRNXSaleCommon Stock5k$19.59$98k 07/26/2021
07/26/2021Crinetics Pharmaceuticals, Inc.CRNXExerciseNon-qualified stock option (Right to Buy)5k$1.91$9.6k 07/26/2021
07/19/2021Crinetics Pharmaceuticals, Inc.CRNXSaleCommon Stock5k$19.50$97.5k 07/19/2021
07/19/2021Crinetics Pharmaceuticals, Inc.CRNXExerciseNon-qualified stock option (Right to Buy)5k$1.91$9.6k 07/19/2021
07/12/2021Crinetics Pharmaceuticals, Inc.CRNXSaleCommon Stock5k$20.71$103.6k 07/12/2021
07/12/2021Crinetics Pharmaceuticals, Inc.CRNXExerciseNon-qualified stock option (Right to Buy)5k$1.91$9.6k 07/12/2021
06/24/2021Ultragenyx Pharmaceutical Inc.RAREGrantStock Option (Right to Buy)4.1k$93.20$384.4k 06/24/2021
06/24/2021Ultragenyx Pharmaceutical Inc.RAREGrantCommon Stock2.1k$0.00$0 06/24/2021
06/22/2021Crinetics Pharmaceuticals, Inc.CRNXGrantStock Option (right to buy)17.5k$20.23$354k 06/22/2021
06/08/2021Atara Biotherapeutics, Inc.ATRAGrantNon-Qualified Stock Option (Right to Buy)17.5k$13.80$241.5k 06/08/2021
06/08/2021Atara Biotherapeutics, Inc.ATRAGrantCommon Stock11k$0.00$0 06/08/2021
07/06/2020Ultragenyx Pharmaceutical Inc.RARESaleCommon Stock6.2k$90.00$556.3k 07/06/2020
07/06/2020Ultragenyx Pharmaceutical Inc.RAREExerciseStock Option (Right to Buy)6.2k$21.00$129.8k 07/06/2020
07/01/2020Ultragenyx Pharmaceutical Inc.RARESaleCommon Stock5k$85.00$425k 07/01/2020
07/01/2020Ultragenyx Pharmaceutical Inc.RAREExerciseStock Option (Right to Buy)5k$21.00$105k 07/01/2020
06/26/2020Ultragenyx Pharmaceutical Inc.RAREGrantCommon Stock2.6k$0.00$0 06/26/2020
06/26/2020Ultragenyx Pharmaceutical Inc.RAREGrantStock Option (Right to Buy)4.2k$76.58$325.5k 06/26/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy